|
US4777964A
(en)
|
1986-01-02 |
1988-10-18 |
David Briggs |
System for obtaining blood samples and submitting for testing of aids
|
|
US5096830A
(en)
|
1987-11-17 |
1992-03-17 |
Adeza Biomedical Corporation |
Preterm labor and membrane rupture test
|
|
US5223440A
(en)
|
1987-11-17 |
1993-06-29 |
Adeza Biomedical Corporation |
Ex vivo product of conception test to determine abortion
|
|
US5281522A
(en)
|
1988-09-15 |
1994-01-25 |
Adeza Biomedical Corporation |
Reagents and kits for determination of fetal fibronectin in a vaginal sample
|
|
US4919889A
(en)
|
1988-09-15 |
1990-04-24 |
Aspen Diagnostics Corporation |
Sample collection and transport fluid composition
|
|
EP0642667B1
(en)
|
1991-11-04 |
2001-01-10 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for preterm delivery
|
|
WO1993009432A1
(en)
|
1991-11-04 |
1993-05-13 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
US5516702A
(en)
|
1991-11-06 |
1996-05-14 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
US5898005A
(en)
|
1993-02-24 |
1999-04-27 |
Dade Behring Inc. |
Rapid detection of analytes with receptors immobilized on soluble submicron particles
|
|
JP3366978B2
(ja)
|
1993-02-24 |
2003-01-14 |
デイド、ベーリング、インコーポレイテッド |
特異的結合性アッセイ試薬の固定化
|
|
ATE226959T1
(de)
|
1993-03-23 |
2002-11-15 |
Victor Voroteliak |
Methode zur detektion von rissen in amniomembranen bei schwangeren säugetieren
|
|
US5431171A
(en)
|
1993-06-25 |
1995-07-11 |
The Regents Of The University Of California |
Monitoring fetal characteristics by radiotelemetric transmission
|
|
WO1995006877A1
(en)
|
1993-09-03 |
1995-03-09 |
Behringwerke Ag |
Fluorescent oxygen channeling immunoassays
|
|
US5650394A
(en)
|
1993-11-04 |
1997-07-22 |
Adeza Biomedical |
Use of urinastatin-like compounds to prevent premature delivery
|
|
US5597700A
(en)
|
1994-04-28 |
1997-01-28 |
California Research, Llc |
Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
|
|
US6140099A
(en)
|
1994-05-20 |
2000-10-31 |
The Trustees Of The University Of Pennsylvania |
Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
|
|
US5641636A
(en)
|
1994-05-20 |
1997-06-24 |
University Of Pennsylvania |
Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
|
|
JP3064015B2
(ja)
|
1995-01-26 |
2000-07-12 |
メルク フロスト カナダ アンド カンパニー |
プロスタグランジンレセプターｄｐ
|
|
WO1997016461A1
(en)
|
1995-10-31 |
1997-05-09 |
Maruha Corporation |
Monoclonal antibody specific for prostaglandin d synthetase
|
|
US6678669B2
(en)
|
1996-02-09 |
2004-01-13 |
Adeza Biomedical Corporation |
Method for selecting medical and biochemical diagnostic tests using neural network-related applications
|
|
US6120460A
(en)
|
1996-09-04 |
2000-09-19 |
Abreu; Marcio Marc |
Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
|
|
US6544193B2
(en)
|
1996-09-04 |
2003-04-08 |
Marcio Marc Abreu |
Noninvasive measurement of chemical substances
|
|
FI963989L
(fi)
|
1996-10-04 |
1998-04-05 |
Wallac Oy |
Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
|
|
EP0968430A1
(en)
|
1997-03-07 |
2000-01-05 |
Mount Sinai Hospital Corporation |
Methods to diagnose a required regulation of trophoblast invasion
|
|
US6610480B1
(en)
|
1997-11-10 |
2003-08-26 |
Genentech, Inc. |
Treatment and diagnosis of cardiac hypertrophy
|
|
US6875567B1
(en)
|
1997-11-10 |
2005-04-05 |
Genentech, Inc. |
Method of detecting cardiac hypertrophy through probe hybridization and gene expression analysis
|
|
US20020031513A1
(en)
|
1997-11-24 |
2002-03-14 |
Shamir Leibovitz |
Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
|
|
US6394952B1
(en)
|
1998-02-03 |
2002-05-28 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6267722B1
(en)
|
1998-02-03 |
2001-07-31 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6506789B2
(en)
|
1998-06-03 |
2003-01-14 |
Shionogi & Co., Ltd. |
Methods for the treatment of itching comprising administering PGD2 receptor antagonist
|
|
US6126597A
(en)
|
1998-07-22 |
2000-10-03 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6149590A
(en)
|
1998-07-22 |
2000-11-21 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US20010025140A1
(en)
|
1998-07-22 |
2001-09-27 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US7109044B1
(en)
|
1998-09-04 |
2006-09-19 |
Maruha Corporation |
Method of detection and disease state management for renal diseases
|
|
PL347508A1
(en)
|
1998-10-29 |
2002-04-08 |
Regents Board Of |
Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
|
|
JP2000249709A
(ja)
|
1999-02-26 |
2000-09-14 |
Maruha Corp |
冠血管インターベンション施行後の再狭窄の予測方法
|
|
US6126616A
(en)
|
1999-06-21 |
2000-10-03 |
Sanyal; Mrinal K. |
Collection of biological products from human accessory reproductive organs by absorbent systems
|
|
WO2001014882A1
(fr)
|
1999-08-23 |
2001-03-01 |
Bml, Inc. |
Identification des proprietes d'une substance pour les recepteurs de prostaglandine d
|
|
FR2809182B1
(fr)
|
2000-05-18 |
2003-08-15 |
Univ Rene Descartes |
Detection de l'il-6 pour la prevision des risques d'accouchement premature
|
|
US20010053876A1
(en)
|
2000-06-15 |
2001-12-20 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
JP3752219B2
(ja)
|
2000-07-21 |
2006-03-08 |
マルハ株式会社 |
痴呆性疾患の鑑別方法
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
AU2001288410A1
(en)
|
2000-08-28 |
2002-03-13 |
Patrick G. Morand |
Use of blood and plasma donor samples and data in the drug discovery process
|
|
US7217725B2
(en)
|
2000-09-14 |
2007-05-15 |
Allergan, Inc. |
Prostaglandin D2 antagonist
|
|
WO2002032958A2
(en)
|
2000-10-16 |
2002-04-25 |
Bayer Aktiengesellschaft |
Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
|
|
US7635571B2
(en)
|
2000-12-07 |
2009-12-22 |
Siemens Healthcare Diagnostics Products Gmbh |
Amplified signal in binding assays
|
|
AU2002302248B2
(en)
|
2001-05-23 |
2008-03-06 |
Merck Frosst Canada Ltd. |
Dihydropyrrolo[1,2-A]indole and tetrahydropyrido[1,2-A]-indole derivatives as prostaglandin D2 receptor antagonists
|
|
CA2454347A1
(en)
|
2001-07-18 |
2003-01-30 |
Merck Frosst Canada & Co./Merck Frosst Canada & Cie |
Eosinophil prostaglandin d2 receptor assays
|
|
US20040197834A1
(en)
|
2001-07-20 |
2004-10-07 |
Francois Gervais |
Method to increase expression of pgd2 receptors and assays for identifying modulators of prostaglandin d2 receptors
|
|
US20050101841A9
(en)
|
2001-12-04 |
2005-05-12 |
Kimberly-Clark Worldwide, Inc. |
Healthcare networks with biosensors
|
|
US20060166295A1
(en)
|
2002-07-01 |
2006-07-27 |
James Woods |
Method for determination of likelihood of occurrence of preterm labor in pregnant females
|
|
US7435419B2
(en)
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
|
KR101215701B1
(ko)
|
2002-07-19 |
2012-12-26 |
베스 이스라엘 데코니스 메디칼 센터 |
자간전증 또는 자간의 진단 및 치료 방법
|
|
WO2004014220A2
(en)
|
2002-08-13 |
2004-02-19 |
N-Dia, Inc. |
Devices and methods for detecting amniotic fluid in vaginal secretions
|
|
EP1537420B1
(en)
|
2002-08-29 |
2010-10-06 |
Diagnostic Technologies Ltd. |
Method of diagnosis of pregnancy-related complications
|
|
JPWO2004030674A1
(ja)
|
2002-09-30 |
2006-01-26 |
塩野義製薬株式会社 |
プロスタグランジンｄ▲下２▼、プロスタグランジンｄ▲下２▼アゴニストおよびプロスタグランジンｄ▲下２▼アンタゴニストの新規用途
|
|
WO2004037206A2
(en)
|
2002-10-23 |
2004-05-06 |
University Of Hawaii |
Methods for diagnosing and treating pre-term labor
|
|
US20040100376A1
(en)
|
2002-11-26 |
2004-05-27 |
Kimberly-Clark Worldwide, Inc. |
Healthcare monitoring system
|
|
WO2004072638A1
(en)
|
2003-02-05 |
2004-08-26 |
Ciphergen Biosystems, Inc. |
Non-invasive assessment of intra-amniotic environment
|
|
US20040266025A1
(en)
|
2003-02-06 |
2004-12-30 |
Durlin Hickok |
Screening and treatment methods for prevention of preterm delivery
|
|
US7191068B2
(en)
|
2003-03-25 |
2007-03-13 |
Proteogenix, Inc. |
Proteomic analysis of biological fluids
|
|
US8068990B2
(en)
|
2003-03-25 |
2011-11-29 |
Hologic, Inc. |
Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
|
|
US20040203079A1
(en)
|
2003-04-09 |
2004-10-14 |
Research Foundation Of The State University Of New York |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US8003765B2
(en)
|
2003-04-09 |
2011-08-23 |
Stony Brook Anaesthesiology, University Faculty Practice Corporation |
Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
|
|
US20070003992A1
(en)
|
2003-04-09 |
2007-01-04 |
Pentyala Srinivas N |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US8060195B2
(en)
|
2003-05-02 |
2011-11-15 |
The Johns Hopkins University |
Devices, systems and methods for bioimpedance measurement of cervical tissue and methods for diagnosis and treatment of human cervix
|
|
US20070054951A1
(en)
|
2003-05-20 |
2007-03-08 |
Lianhai Li |
Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists
|
|
WO2005007223A2
(en)
|
2003-07-16 |
2005-01-27 |
Sasha John |
Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
|
|
JP3897117B2
(ja)
|
2003-09-24 |
2007-03-22 |
マルハ株式会社 |
妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法
|
|
JP4354954B2
(ja)
|
2003-09-26 |
2009-10-28 |
株式会社マルハニチロ水産 |
関節リウマチの検出又は鑑別方法及び病期又は機能障害度の判別方法
|
|
US20050131287A1
(en)
|
2003-12-16 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Detection of premature rupture of the amniotic membrane
|
|
JP2008514900A
(ja)
|
2004-07-30 |
2008-05-08 |
アデザ・バイオメデイカル・コーポレイシヨン |
疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法
|
|
US20080090759A1
(en)
|
2004-08-30 |
2008-04-17 |
Robert Kokenyesi |
Methods and kits for predicting risk for preterm labor
|
|
US20080254479A1
(en)
|
2004-08-30 |
2008-10-16 |
Cervimark, Llc |
Methods and Kits For Predicting Risk For Preterm Labor
|
|
EP2347765B1
(en)
|
2004-09-24 |
2014-01-22 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating complications of pregnancy
|
|
GB0422057D0
(en)
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
|
GT200500284A
(es)
|
2004-10-15 |
2006-03-27 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
EP1839056B1
(en)
|
2004-12-21 |
2011-08-03 |
Yale University |
Diagnosis of preeclampsia
|
|
US20060166242A1
(en)
|
2005-01-06 |
2006-07-27 |
Mount Sinai Hospital |
Markers of pre-term labor
|
|
DOP2006000016A
(es)
|
2005-01-26 |
2006-07-31 |
Aventis Pharma Inc |
2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
|
|
GB0505048D0
(en)
|
2005-03-11 |
2005-04-20 |
Oxagen Ltd |
Compounds with PGD antagonist activity
|
|
US20060257901A1
(en)
*
|
2005-03-24 |
2006-11-16 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
|
|
JP2009501715A
(ja)
|
2005-07-13 |
2009-01-22 |
イーシーアイ バイオテック インコーポレイティッド |
女性の状態を評価するための基質、センサー、および方法
|
|
JP5064219B2
(ja)
|
2005-07-22 |
2012-10-31 |
塩野義製薬株式会社 |
Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体
|
|
US7863007B2
(en)
|
2005-09-15 |
2011-01-04 |
Swiss Asian Property Limited |
Marker for prolonged rupture of membranes
|
|
GT200600457A
(es)
|
2005-10-13 |
2007-04-27 |
Aventis Pharma Inc |
Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
|
|
WO2007047372A2
(en)
|
2005-10-14 |
2007-04-26 |
The Board Of Trustees Of The University Of Illinois |
Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
|
|
US20070111326A1
(en)
|
2005-11-14 |
2007-05-17 |
Abbott Laboratories |
Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
|
|
US20080009552A1
(en)
|
2006-03-23 |
2008-01-10 |
Craig Pennell |
Markers of pre-term labor
|
|
DOP2007000068A
(es)
|
2006-04-12 |
2007-10-31 |
Sanofi Aventis Us Llc |
Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2
|
|
WO2007149312A2
(en)
|
2006-06-16 |
2007-12-27 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph
|
|
BRPI0714554A2
(pt)
|
2006-07-25 |
2013-05-07 |
Sanofi Aventis |
2-fenil-indàis como antagonistas do receptor de prostaglandina d2
|
|
WO2008039941A2
(en)
|
2006-09-27 |
2008-04-03 |
The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services |
Scgb3a2 as a growth factor and anti-apoptotic agent
|
|
MX2009003518A
(es)
|
2006-10-03 |
2009-08-25 |
Genzyme Corp |
Uso de antagonistas de tgf-beta para tratar a los infantes en riesgo de desarrollar displasia brocopulmonar.
|
|
WO2008073491A1
(en)
|
2006-12-11 |
2008-06-19 |
University Of Florida Research Foundation, Inc. |
System and method for analyzing progress of labor and preterm labor
|
|
CA2672373C
(en)
|
2006-12-19 |
2011-08-30 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
JP5194212B2
(ja)
|
2006-12-26 |
2013-05-08 |
ブリガム・ヤング・ユニバーシティ |
血清プロテオミクスシステムと関連する方法
|
|
EP2132196A1
(en)
|
2007-02-26 |
2009-12-16 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
US20090058072A1
(en)
|
2007-08-30 |
2009-03-05 |
Shirlee Ann Weber |
Record sheets with integrated themes
|
|
US20100251394A1
(en)
|
2007-09-20 |
2010-09-30 |
The Johns Hopkins University |
Treatment and prevention of ischemic brain injury
|
|
US20110002866A1
(en)
|
2007-10-31 |
2011-01-06 |
Lubit Beverly W |
Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
|
|
WO2009059259A2
(en)
|
2007-10-31 |
2009-05-07 |
Children's Hospital Medical Center |
Detection of worsening renal disease in subjects with systemic lupus erythematosus
|
|
US20100298368A1
(en)
|
2007-11-06 |
2010-11-25 |
Amira Pharmaceuticals, Inc. |
Antagonists of pgd2 receptors
|
|
US20110065139A1
(en)
|
2007-11-27 |
2011-03-17 |
Jacob Mullerad |
diagnostic device for identifying rupture of membrane during pregnancy
|
|
US20130177485A1
(en)
|
2007-11-27 |
2013-07-11 |
Momtec Life Ltd. Of Yazmot Haemek |
Diagnostic device for identifying rupture of membrane during pregnancy
|
|
DK2229358T3
(da)
|
2007-12-14 |
2011-07-04 |
Pulmagen Therapeutics Asthma Ltd |
Indoler og deres terapeutiske anvendelse
|
|
CA2711071A1
(en)
|
2008-01-07 |
2009-07-16 |
Ortho-Clinical Diagnostics, Inc. |
Determination of sflt-1:angiogenic factor complex
|
|
WO2009090399A1
(en)
|
2008-01-18 |
2009-07-23 |
Argenta Discovery Limited |
Indoles active on crth2 receptor
|
|
WO2009094665A1
(en)
|
2008-01-25 |
2009-07-30 |
Perkinelmer Health Sciences, Inc. |
Methods for determining the risk of prenatal complications
|
|
WO2009097584A1
(en)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Maternal serum biomarkers for detection of pre-eclampsia
|
|
WO2009097579A1
(en)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
|
|
BRPI0907364A2
(pt)
|
2008-02-01 |
2015-07-14 |
Amira Pharmaceuticals Inc |
Antagonistas aminoalquilbifenil n,n-disubstituídos de receptores d2 de prostaglandina
|
|
WO2009099901A1
(en)
|
2008-02-01 |
2009-08-13 |
Amira Pharmaceuticals, Inc. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
WO2009102893A2
(en)
|
2008-02-14 |
2009-08-20 |
Amira Pharmaceuticals, Inc. |
CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
|
|
JP2011513242A
(ja)
|
2008-02-25 |
2011-04-28 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体アンタゴニスト
|
|
US8426449B2
(en)
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
RU2501573C2
(ru)
|
2008-05-16 |
2013-12-20 |
Кортера, Инк. |
Способ предупреждения преждевременных родов
|
|
WO2010008864A2
(en)
|
2008-06-24 |
2010-01-21 |
Amira Pharmaceuticals, Inc. |
Cycloalkane[b]indole angtagonists of prostaglandin d2 receptors
|
|
US8071807B2
(en)
|
2008-07-03 |
2011-12-06 |
Panmira Pharmaceuticals, Llc |
Antagonists of prostaglandin D2 receptors
|
|
FR2934681B1
(fr)
|
2008-07-29 |
2011-09-30 |
Bastien Karkouche |
Dispositif pour la capture de particules biologiques et utilisation.
|
|
WO2010017201A1
(en)
|
2008-08-04 |
2010-02-11 |
The Board Of Regents Of The University Of Texas System |
Multiplexed diagnostic test for preterm labor
|
|
US8536185B2
(en)
|
2008-09-22 |
2013-09-17 |
Cayman Chemical Company, Incorporated |
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
|
|
GB2463788B
(en)
|
2008-09-29 |
2010-12-15 |
Amira Pharmaceuticals Inc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
WO2010042652A2
(en)
|
2008-10-08 |
2010-04-15 |
Amira Pharmaceuticals, Inc. |
Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
|
|
GB2465062B
(en)
|
2008-11-06 |
2011-04-13 |
Amira Pharmaceuticals Inc |
Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US9180114B2
(en)
|
2008-11-26 |
2015-11-10 |
President And Fellows Of Harvard College |
Neurodegenerative diseases and methods of modeling
|
|
US20120004233A1
(en)
|
2009-01-26 |
2012-01-05 |
Amira Pharmaceuticals, Inc |
Tricyclic compounds as antagonists of prostaglandin d2 receptors
|
|
US20120046261A1
(en)
|
2009-02-27 |
2012-02-23 |
University Of Utah Research Foundation |
Compositions and methods for diagnosing and preventing spontaneous preterm birth
|
|
GB0905964D0
(en)
|
2009-04-06 |
2009-05-20 |
King S College London |
Marker
|
|
US8815917B2
(en)
|
2009-08-05 |
2014-08-26 |
Panmira Pharmaceuticals, Llc |
DP2 antagonist and uses thereof
|
|
US20110090048A1
(en)
|
2009-09-29 |
2011-04-21 |
Li Conan K |
Data Transmission Device with User Identification Capability
|
|
CA2779270A1
(en)
|
2009-10-29 |
2011-05-05 |
The Trustees Of The University Of Pennsylvania |
Method of predicting risk of preterm birth
|
|
RU2556524C2
(ru)
|
2009-11-12 |
2015-07-10 |
Сервиленц Инк. |
Устройства и способы для измерения шейки матки
|
|
CA2780976C
(en)
|
2009-11-25 |
2020-03-31 |
Hologic, Inc. |
Detection of intraamniotic infection
|
|
CA2807050C
(en)
|
2009-12-08 |
2019-06-18 |
Ozlem Equils |
Diagnostic biomarker to identify women at risk for preterm delivery
|
|
US8874183B2
(en)
|
2010-02-18 |
2014-10-28 |
The Johns Hopkins University |
Preterm labor monitor
|
|
AR080527A1
(es)
|
2010-03-16 |
2012-04-11 |
Aventis Pharma Inc |
Una pirimidina sustituida como un antagonista del receptor de la postaglandina d2
|
|
MX2012010035A
(es)
|
2010-03-16 |
2012-10-01 |
Aventis Pharma Inc |
Pirimidinas sustituidas como antagonistas del receptor de la prostaglandina d2.
|
|
AR080703A1
(es)
|
2010-03-22 |
2012-05-02 |
Actelion Pharmaceuticals Ltd |
Derivados de 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-carbazol, moduladores de receptores de prostaglandina d2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos alergicos o inmunitarios tales como asma.
|
|
US20110237972A1
(en)
|
2010-03-23 |
2011-09-29 |
Robert Garfield |
Noninvasive measurement of uterine emg propagation and power spectrum frequency to predict true preterm labor and delivery
|
|
US20130045889A1
(en)
*
|
2010-04-13 |
2013-02-21 |
Pronota N.V. |
Biomarkers for hypertensive disorders of pregnancy
|
|
EP2569253A4
(en)
*
|
2010-05-14 |
2013-10-02 |
Beth Israel Hospital |
EXTRACORPORAL DEVICES AND METHOD FOR TREATING COMPLICATIONS DURING PREGNANCY
|
|
US20110312927A1
(en)
|
2010-06-18 |
2011-12-22 |
Satish Kumar Nachaegari |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
US20110312928A1
(en)
|
2010-06-18 |
2011-12-22 |
Lipocine Inc. |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
US20110318308A1
(en)
|
2010-06-25 |
2011-12-29 |
Winthrop-University Hospital |
Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
|
|
CN102958914B
(zh)
|
2010-07-05 |
2015-05-27 |
埃科特莱茵药品有限公司 |
1-苯基取代的杂环衍生物及其作为前列腺素d2受体调节剂的用途
|
|
EP2592992A4
(en)
|
2010-07-12 |
2014-04-23 |
Therasyn Sensors Inc |
DEVICE AND METHOD FOR IN VIVO MONITORING OF PATIENTS
|
|
US8765487B2
(en)
|
2010-09-01 |
2014-07-01 |
Clinical Innovations |
Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
|
|
BR112013007311A2
(pt)
|
2010-10-01 |
2016-07-05 |
Hologic Inc |
tira de teste de imunoensaio para uso em um sistema de diagnóstico
|
|
US10669569B2
(en)
|
2010-10-15 |
2020-06-02 |
Navinci Diagnostics Ab |
Dynamic range methods
|
|
US20120142559A1
(en)
|
2010-12-06 |
2012-06-07 |
Pronota N.V. |
Biomarkers and parameters for hypertensive disorders of pregnancy
|
|
GB201101621D0
(en)
|
2011-01-31 |
2011-03-16 |
Olink Ab |
Method and product
|
|
CA2821355A1
(en)
|
2011-01-31 |
2012-08-09 |
Esoterix Genetic Laboratories, Llc |
Methods for enriching microparticles or nucleic acids using binding molecules
|
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
|
JP6034394B2
(ja)
*
|
2011-11-09 |
2016-11-30 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
切迫妊娠高血圧腎症および／またはＨＥＬＬＰ症候群の指標としてのｓＦｌｔ−１またはエンドグリン／ＰｌＧＦ比の動態
|
|
EP2812698B1
(en)
|
2012-02-06 |
2020-10-28 |
PerkinElmer Health Sciences Canada, Inc. |
Dual-acceptor time-resolved-fret
|
|
CN104487593A
(zh)
|
2012-05-08 |
2015-04-01 |
斯坦福大学托管董事会 |
用于提供先兆子痫评估的方法和组合物
|
|
MX356775B
(es)
|
2012-06-27 |
2018-06-13 |
Hoffmann La Roche |
Medios y metodos que aplican sflt-1/plgf o relacion de endoglina/plgf para descartar el inicio de preeclampsia en un determinado periodo de tiempo.
|
|
WO2014036440A2
(en)
|
2012-08-30 |
2014-03-06 |
Ansh Labs Llc |
Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
|
|
ES2690782T3
(es)
|
2012-10-24 |
2018-11-22 |
Nyu Winthrop Hospital |
Biomarcador no invasivo para identificar sujetos en riesgo de parto prematuro
|
|
WO2014078622A1
(en)
*
|
2012-11-15 |
2014-05-22 |
The Brigham And Women's Hospital, Inc. |
Method and system for diagnosing and treating preeclampsia
|
|
CA2903929A1
(en)
*
|
2013-03-04 |
2014-09-12 |
Iq Products B.V. |
Prognostic marker to determine the risk for early-onset preeclampsia
|
|
JP6639392B2
(ja)
*
|
2013-12-03 |
2020-02-05 |
セザンヌ ソシエテ パ アクシオンス シンプリフィエ |
胎盤成長因子２の選択的測定法
|
|
EP3097422B1
(en)
|
2014-01-24 |
2018-07-11 |
Roche Diagnostics GmbH |
Prediction of postpartum hellp syndrome, postpartum eclampsia or postpartum preeclampsia
|
|
WO2015148989A1
(en)
|
2014-03-27 |
2015-10-01 |
Wayne State University |
Systems and methods to identify and treat subjects at risk for obstetrical complications
|
|
EP3175239A1
(en)
|
2014-07-30 |
2017-06-07 |
Matthew Cooper |
Methods and compositions for diagnosing, prognosing, and confirming preeclampsia
|
|
WO2016132136A1
(en)
*
|
2015-02-18 |
2016-08-25 |
Aston University |
Diagnostic assay and treatment for preeclampsia
|
|
WO2016134324A1
(en)
|
2015-02-20 |
2016-08-25 |
Neoteryx, Llc |
Method and apparatus for acquiring blood for testing
|
|
US20180114600A1
(en)
|
2015-03-23 |
2018-04-26 |
Adelaide Research & Innovation Pty Ltd |
Methods and systems for determining risk of a pregnancy complication occurring
|
|
CA2998275A1
(en)
|
2015-09-11 |
2017-03-16 |
Universidad De Los Andes |
In vitro method for identifying a pregnancy related disease
|
|
NL2016967B1
(en)
|
2016-06-15 |
2017-12-21 |
Iq Products B V |
Markers and their ratio to determine the risk for early-onset preeclampsia.
|
|
US20190353667A1
(en)
|
2017-02-06 |
2019-11-21 |
Astute Medical, Inc. |
Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
|
|
US20190079097A1
(en)
|
2017-09-13 |
2019-03-14 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|
|
CA3075688A1
(en)
|
2017-09-13 |
2019-03-21 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|